不同剂量加味芍甘附子汤对胶原诱导性关节炎大鼠干预作用及安全性研究

doi:10.19803/j.1672-8629.2022.09.07

摘要/Abstract

摘要： 目的探讨不同剂量加味芍甘附子汤对胶原诱导性关节炎（collagen-induced arthritis,CIA）大鼠炎性细胞因子和安全性指标的影响,研究其疗效和安全性。方法 Wistar大鼠36只,根据体重随机分为6组：正常组,CIA模型组,对照组及中药低、中、高剂量组,每组6只。正常组常规饲养,其余各组复制CIA寒证模型后,模型组生理盐水灌胃,对照组雷公藤多苷（6.25 mg·kg^-1）灌胃,中药组加味芍甘附子汤低、中、高剂量（0.625、1.25、2.5 g·mL^-1）灌胃,干预4周,测定各组大鼠关节炎症指数评分、踝关节滑膜病理学改变、外周血IL-6水平,心（肌钙蛋白）、肝（CK18、HMGB1、GLDH）、肾（NGAL、胱抑素C）早期预警及常规安全性指标。结果干预4周后,加味芍甘附子汤中、高剂量组AI评分较CIA模型组显著降低（P<0.05）;病理结果显示加味芍甘附子汤各剂量组与模型组相比,关节腔狭窄、滑膜细胞增生、淋巴细胞浸润及关节面受损减轻;加味芍甘附子汤中、高剂量组血清IL-6水平较CIA模型组降低（P<0.05）;各组大鼠外周血生化指标及CK18、HMGB1、胱抑素C水平组间差异无统计学意义;对照组及中药低、中、高剂量组GLDH水平较正常组降低（P<0.05）;对照组NGAL水平较正常组升高（P<0.05）;对照组及低剂量组肌钙蛋白水平较正常组降低（P<0.05）。结论不同剂量加味芍甘附子汤均未出现心、肝、肾脏毒性作用,并能减轻关节肿胀,降低IL-6水平,为后续相关研究和临床应用提供实验基础。

关键词: 胶原诱导性关节炎, 类风湿关节炎, 加味芍甘附子汤, 温经通络法, 安全性

Abstract: Objective To investigate the effects of different doses of modified Shaoganfuzi Decoction on inflammatory cytokines and safety indexes in rats with collagen-induced arthritis, and to study its efficacy and safety. Methods Thirty-six Wistar rats were randomly divided into 6 groups according to their body weight: normal group, CIA model group, control group, and traditional Chinese medicine group with low, medium and high dose groups, with 6 rats in each group. The normal group was fed routinely, after the CIA cold syndrome model was replicated in the other groups, the model group was gavaged with normal saline, the control group was gavaged with Tripterygium wilfordii polyglycosides (6.25 mg·kg^-1), and the traditional Chinese medicine group was given low, medium and high doses of modified Shaoganfuzi decoction. (0.625 g·mL^-1, 1.25 g·mL^-1, 2.5 g·mL^-1) were intragastrically administered and intervened for 4 weeks. The joint inflammation index score, the pathological changes of the ankle joint synovium and the peripheral blood inflammatory cytokine IL-6 were measured in each group. levels, and cardiac (troponin), liver (CK18, HMGB1, GLDH), kidney (NGAL, cystatin C) early warning and routine safety indicators. Results After 4 weeks of intervention, the AI scores of the middle and high dose groups of modifined Shaoganfuzi Decoction were significantly lower than those of the CIA model group (P<0.05). Stenosis, synovial cell hyperplasia, lymphocyte infiltration and articular surface damage were alleviated; serum IL-6 levels in the middle and high doses of modifined Shaoganfuzi decoction groups were lower than those in the CIA model group (P<0.05); peripheral blood biochemical changes of rats in each group There was no significant difference in the indexes and the levels of CK18, HMGB1 and cystatin C between the groups; the levels of GLDH in the control group and the low, middle and high doses of traditional Chinese medicine groups were lower than those in the normal group (P<0.05); the levels of NGAL in the control group were higher than those in the normal group (P<0.05); the levels of troponin in the control group and low-dose group were lower than those in the normal group (P<0.05). Conclusion Modified Shaoganfuzi Decoction has no toxic effects on the heart, liver and kidney, and can reduce joint swelling and IL-6 level, which provides the basis for subsequent research and clinical application.

Key words: collagen-induced arthritis, rheumatoid arthritis, modified Shaoganfuzi decoction, warming meridians and collaterals, safety

中图分类号:

R994.11

李媛, 柏志义, 王海瑜, 钱唐亮, 王若伊, 康天伦, 杜梦梦, 白雪娇, 刘小平, 侯秀娟. 不同剂量加味芍甘附子汤对胶原诱导性关节炎大鼠干预作用及安全性研究[J]. 中国药物警戒, 2022, 19(9): 962-966.

LI Yuan, BAI Zhiyi, WANG Haiyu, QIAN Tangliang, WANG Ruoyi, KANG Tianlun, DU Mengmeng, BAI Xuejiao, LIU Xiaoping, HOU Xiujuan. Interventional effect and safety of modified Shaoganfuzi decoction with different doses in CIA rats[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 962-966.

参考文献

[1] MARCUCCI E,BARTOLONI E,ALUNNO A,et al.Extra-articular rheumatoid arthritis[J]. Reumatismo, 2018,70(4):212-224.
[2] SMOLEN JS, ALETAHA D, BARTON A, et al.Rheumatoid arthritis.[J] Nat Rev Dis Primers. 2018 ; 4(1): 18001.
[3] PANG YZ,LUO ZH,TANG QQ,et al.chinese medicine pathogenesis syndrome element of rheumatoid arthritis:discussion on bi-syndrome pathological factors[J].Journal of Traditional Chinese Medicine(中医杂志), 2018, 59(5):4.
[4] ZHENG W,ZHU YL,MA JF,et al.Clinical observation on jiawei shaogan fuzi decoction combined with western medicine in the treatment of 30 rheumatoid arthritis patients with cold-damp obstruction syndrome at active phase[J].Journal of Traditional Chinese Medicine(中医杂志),2018,59(9):760-764.
[5] MA JF,HOU XJ,LIU XP,et al.Establishment and evaluation of cold syndrome animal model with rheumatoid arthritis[J].China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2016,31(5): 1967-1970.
[6] SUN YQ.Effect and mechanism of aconite decocton on rheumatoid arthritis[D].China Academy of Chinese Medical Sciences(中国中医科学院),2012.
[7] XU SY,BIAN RL, CHEN X.Experimental Methodology of Pharmacology (药理实验方法学)[M].Beijing ; People's Medical Publishing House , 2002: 23.
[8] MAO X, ChEN WJ, LI YF , et al.An exploration into the therapeutic effects and molecular mechanisms of paeoniflorin in the treatment of adjuvant-induced arthritis rats by a network pharmacology-based research strategy[J].Acta Pharmaceutica Sinica(药学学报),2019,54(11):2000-2010.
[9] SHAOX,YUAN YS,JIANG XH,et al.Effect of aconitine on proliferation, apoptosis and autophagy of fibroblast-like synoviocytes in rheumatoid arthritis[J].Chinese Journal of Immunology(中国免疫学杂志), 2019, 35(24): 3066-3070, 3074.
[10] HU ZP, HE SQ, WANG CM, et al.Glycyrrhizic acid inhibits PI3K/AKT/NF-κB attenuating inflammatory response in collagen-induced rheumatoid arthritis rats[J].Chinese Journal of Gerontology(中国老年学杂志), 2020, 40(13): 2852-2856.
[11] JING WX,ZHU YL,HOU XJ,et al.Intervention of angiogenesis in the rats of collagen induced arthritis treated with the therapy for warming meridians and circulating collaterals[J].World Journal of Integrated Traditional and Western Medicine(世界中西医结合杂志), 2013, 8(5): 502-506.
[12] YUAN F,ZHU YL.Mechanism study of modified Shaogan Fuzi decoction on the angiogenesis inhibitor factors in the synovial of rats with collagen-induced arthritis[J].Beijing Journal of Traditional Chinese Medicine(北京中医药), 2014, 33(7): 551-554.
[13] LIU Y, ZHU YL, HXJ,et al.Effects of modified Shaogan Fuzi decoction on angiogenesis relating factors in the synovial tissue of CIA rats[J].Global Traditional Chinese Medicine(环球中医药), 2015, 8(6): 692-696.
[14] ZHANG YT,HOU XJ,LIU XP,et al.Effect of modified Shaogan Fuzi Decoction on the pathology of joint synovium and expression level of serum IL-2,IL-17A and TNF-ɑ in rats with collagen induced arthritis[J].Journal of Tianjin University of Traditional Chinese Medicine(天津中医药大学学报), 2021, 40(1): 93-97.
[15] LIU XP, MA JF, ZHENG W,et al.IFN-γ and IL-17A in rats with CIA cold syndrome treated by modified Shaogan Fuzi decoction effect of expression[J]. Global Traditional Chinese Medicine(环球中医药), 2018, 11(2): 167-171.
[16] BRZUSTEWICZ E, BRYL E.The role of cytokines in the pathogenesis of rheumatoid arthritis--practical and potential application of cytokines as biomarkers and targets of personalized therapy[J]. Cytokine. 2015, 76(2): 527-536.
[17] SCHINNERLING K, AGUILLóN JC, CATALáN D, et al. The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis[J]. Clin Exp Immunol. 2017 , 189(1): 12-20.
[18] ZHAO H,YANG QF,LI MQ.Advances in studies on toxicity of aconite[J].Hebei Journal of Traditional Chinese Medicine(河北中医), 2017, 39(5): 774-777.
[19] KORVER S, BOWEN J, PEARSON K, et al.The application of cytokeratin-18 as a biomarker for drug-induced liver injury[J]. Arch Toxicol, 2021, 95(11): 3435-3448.
[20] THULIN P, HORNBY RJ, AULI M, et al.A longitudinal assessment of miR-122 and GLDH as biomarkers of drug-induced liver injury in the rat[J]. Biomarkers, 2017, 22(5): 461-469.
[21] LEA JD, CLARKE JI, MCGUIRE N, et al.redox-dependent hmgb1 isoforms as pivotal co-ordinators of drug-induced liver injury: mechanistic biomarkers and therapeutic targets[J]. Antioxid Redox Signal, 2016,24(12):652-665.
[22] CHEN Y, SUN W, GAO R, et al.The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis[J]. Rheumatology (Oxford), 2013 , 52(10): 1739-1747.
[23] BARNAY-VERDIER S, GAILLARD C, MESSMER M, et al.PCA-ELISA: a sensitive method to quantify free and masked forms of HMGB1[J]. Cytokine, 2011 , 55(1): 4-7.
[24] ABASSI Z, SAGI O, ARMALY Z, et al.Neutrophil gelatinase-associated lipocalin (NAGL): a novel biomarker for acute kidney injury[J]. Harefuah, 2011, 150(2): 111-116.